跳至主要内容
临床试验/ACTRN12617000922370
ACTRN12617000922370招募中1 期

nderstanding the Inflammatory mechanisms and effect of Colchicine in patients with End stage renal failure undergoing Dialysis

A/Prof Sanjay Patel0 个研究点目标入组 100 人开始时间: 2017年6月26日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Patients with end stage renal failure on haemodialysis

排除标准

  • Known hypersensitivity to colchicine
  • Moderate hepatic dysfunction (Alanine Aminotransferase 1.5x upper limit of normal range)
  • Thrombocytopaenia or leukopaenia
  • Pregnant or lactating women and women at risk of pregnancy
  • Patients taking moderate-strong CYP3A4 inhibitors
  • Patients already taking Colchicine
  • Those with evidence of active infection of inflammatory conditions that might be associated with markedly elevated CRP levels in the blood and those taking other anti-inflammatory therapies

研究者

发起方
A/Prof Sanjay Patel

相似试验